The concept of evidence-based medicine (EBM) has been invented by physicians mostly from English Canada, mostly from McMaster University, Ontario, Canada. The term EBM first appeared in the biomedical literature in 1991 in an article written by a prominent member of this group—Gordon Guyatt from McMaster University. The inventors of EBM have also created the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) working group, which is a prominent international organisation whose main purpose is to develop evidence-based clinical practice guidelines (CPGs). CPGs that are based on the GRADE approach are becoming increasingly adopted worldwide, in particular by many professional or governmental organisations. This group of thinkers being thus identified, we have retrieved and read many of their publications in order to try and understand how they intend to incorporate bioethical values into their concept. The author of this little essay did also spend a few years on the internet as an active member of the GRADE group discussion list. The observations thus gathered suggest that although some of the inventors of EBM, at least Gordon Guyatt, wish to incorporate core principles of biomedical ethics into their concept (ie, non-malevolence, beneficence and maybe to a lesser extent respect for autonomy, and justice), some clarifications are still necessary in order to better understand how they intend to more explicitly incorporate bioethical values into their concept and, perhaps more importantly, into evidence-based CPGs.
- Evidence-based medicine
- clinical practice guidelines
- applied and professional ethics
- history of health ethics/bioethics
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests Dr Joseph Watine is member of the working group ‘Clinical Practice Guidelines’ of the European Federation of Clinical Chemistry (EFCC), and chairman of the working group ‘Clinical Practice Guidelines and Evidence-Based Laboratory Medicine’ of the Société Française de Biologie Clinique.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case
- Patients’ participation in government-sponsored guidelines in Latin America: a cross-sectional study
- Evaluation of the NCCN guidelines using the RIGHT Statement and AGREE-II instrument: a cross-sectional review
- Answering medical questions at the point of care: a cross-sectional study comparing rapid decisions based on PubMed and Epistemonikos searches with evidence-based recommendations developed with the GRADE approach
- Characteristics and quality of clinical practice guidelines addressing acupuncture interventions: a systematic survey of 133 guidelines and 433 acupuncture recommendations
- A critical appraisal of the methodology and quality of evidence of systematic reviews and meta-analyses of traditional Chinese medical nursing interventions: a systematic review of reviews
- Nutrigenetics, omega-3 and plasma lipids/lipoproteins/apolipoproteins with evidence evaluation using the GRADE approach: a systematic review
- The GRADE approach and Bradford Hill's criteria for causation
- Considerations of complexity in rating certainty of evidence in systematic reviews: a primer on using the GRADE approach in global health
- Grading recommendations in clinical practice guidelines: randomised experimental evaluation of four different systems